BRIEF-ALK Abelló: Marketing authorisation for Acarizax issued in France

* Says that authorities in France have issued a marketing authorisation for ALK's new house dust mite sublingual allergy immuno-therapy tablet (slit-tablet), Acarizax Source text for Eikon:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.